Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30776751 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Zinc Ion SCHEMBL29443816 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 | |
| Potassium Ion SCHEMBL30738473 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL16504394 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL7522991 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL30697531 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL423063 | 0.93 | CA4 (0.47) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL16504393 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL30542449 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 | |
| SCHEMBL30045530 | 0.93 | CA4 (0.41) | CA4CASP1FFAR3HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260031400-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2026-01-29 | — | — | US | disclosed |
| CN-119816980-A | Electrolyte for electric storage device, reinforcing agent, electrolyte solution, and electric storage device using same | 富山药品工业株式会社 | 2025-04-11 | — | — | CN | disclosed |
| EP-4525123-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | Tomiyama Pure Chemical Industries, Limited (JP) | 2025-03-19 | — | — | EP | disclosed |
| CN-118930665-A | Preparation of cellulose carboxylic monoester lithium and application of cellulose carboxylic monoester lithium as lithium battery electrode adhesive | 贵州大学 | 2024-11-12 | — | — | CN | disclosed |
| WO-2024225238-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | 富山薬品工業株式会社 | 2024-10-31 | — | — | WO | disclosed |
| CN-112838267-B | Polymer-based electrolyte, preparation method thereof and solid-state battery | 郑州宇通集团有限公司 | 2022-09-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260031400-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | KCNN1, KCNN2, ILK | CA4 3830/4885CASP1 2944/4885FFAR3 3720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.